GIST Support International - logo

GIST Support International - Ask the Professional
GIST Imagery

Periodically GIST Support International  poses questions to physicians, researchers, and other experts about gastrointestinal stromal tumor (GIST cancer).  Their answers to our questions are posted to this page for the education and support of GIST patients and their caregivers, family, and friends.

Title (click to link)

Authors

PET Imaging for GIST Annick D. Van den Abbeele MD

Switch Pocket Kinase Inhibitors

Scott C. Wise MS and
Bryan D. Smith PhD
Kidney Function and GIST Drugs Benjamin Humphreys MD PhD
Understanding Your Pathology Report for GIST Jason L. Hornick MD PhD and
Alexander J.F. Lazar MD PhD
edited by Julia D. Royster PhD
Nomogram for Estimating the Probability of Recurrence-Free Survival after Surgical Resection of Primary GIST Ronald P. DeMatteo, MD FACS
Adjuvant Imatinib Opinions Jean-Yves Blay, MD PhD and
Jonathan Trent II MD PhD
GIST with PDGFR Alpha Mutations Abhijit Ramachandran, MS
Surgical Considerations: Margins, Adhesions, and Desmoids Raphael E. Pollock, MD PhD FACS
HSP90 Inhibitors and GIST Sebastian Bauer, MD and Jonathan Fletcher, MD
Radiation Treatment for GIST Ian Judson, MD FRCP
Thyroid Damage from Tyrosine Kinase Inhibitors Patrick Schöffski, MD, MPH,  and
Pascal Wolter, MD
Nutrition and GI Issues After GIST Surgery Kursheed N. Jeejeebhoy, MD, FRCP(C), PhD
Sunitinib (Sutent) Experience in Use Peter Reichardt, MD PhD
Nutritional Needs After Gastrointestinal Surgery Ponnandai S. Somasundar, MD FACS, and N. Joseph Espat, MD FACS
Insulin-like Growth Factor Receptor 1 in GIST Andrew Godwin, PhD
Genetic Factors in Gastrointestinal Stromal Tumor (GIST) Kelly Branda, MS CGC 
and Irene Rainville, PhD CGC
Esophageal GIST Matthew G. Blum, M.D.
Radiation Exposure from CT Scans Donald P. Frush, M.D.
New Findings in the Genetics of Carney-Stratakis Syndrome and Carney Triad Constantine A. Stratakis, MD ScD
Skin-Related Side Effects of Imatinib & Sunitinib Mario E. Lacouture, MD
The Cell Cycle as a Drug Target Gary K. Schwartz, MD
Z9001 Adjuvant Gleevec Trial Ronald P. DeMatteo, MD FACS
Sunitinib and Hypertension Robert Maki, MD PhD and Michele Bradshaw, PharmD
GIST Pathology and Prognosis Markku Miettinen, M.D.Ph.D. and Jerzy Lasota, M.D. Ph.D.
Case History of A Family with GIST Jonathan C. Trent, M.D. Ph.D.
Gleevec and Bone Health Robert Maki, M.D. Ph.D.
Abdominal Anatomy for GIST:
Peritoneum and Retroperitoneum
Christopher Windham, M.D.
Imaging GIST Response to Treatment Haesun Choi, M.D.
Effects of Imatinib (Gleevec) on GIST Cells Jonathan C. Trent, M.D. Ph.D.
A slide show presentation from the Third International Conference for Organizations Representing People with CML or GIST Peter Reichardt, MD
The Story of Discovery of the Carney Triad J. Aidan Carney, M.D., Ph.D., F.R.C.P.I., F.R.C.P.
Social Security Disability Frances Paulson Motley
Can a needle biopsy be harmful to a GIST patient? Christopher Corless, M.D. Ph.D.
GIST and the LIVER Ronald P. DeMatteo, M.D., FACS
Informed Consent James E. Turner, M.D.
The Human Side of Cancer Jimmie C. Holland, M.D.

 

 



back to top